EDOC


Telemedicine & Digital Health ETF

Reasons to Consider EDOC

High Growth Potential

The global telemedicine market increased 35% from 2019 to 2020, exceeding $55bn. Forecasts suggest the market could reach nearly $300bn by 2028.1

Structural Tailwinds

In 2019, an estimated half of the global population lacked essential health care services.2 As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide.

New Consumer Preferences

The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.

1Grand View Research, Feb 2021
2World Economic Forum

Key Information As of 12/01/22

Inception Date 07/29/20
Total Expense Ratio 0.68%
Net Assets $151.57 million
NAV $12.35
Fact Sheet

ETF Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

ETF Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Trading Details As of 12/01/22

Ticker EDOC
Bloomberg Index Ticker SOLEDOC
CUSIP 37954Y285
ISIN US37954Y2853
Primary Exchange Nasdaq
Shares Outstanding 12,270,000
Number of Holdings 40
30-Day Median Bid-Ask Spread 0.53%

Distributions As of 12/01/22

30-Day SEC Yield 0.25%
Distribution Frequency Semi-Annually

ETF Prices As of 12/01/22

NAV $12.35 Daily Change $0.12 0.97%
Market Price $12.37 Daily Change $0.17 1.39%

Performance History

As of recent
(09/30/22)
As of recent
(09/30/22)
Fund NAV Market Price Index
1 Year -36.19% -36.23% -36.19%
Since Inception -12.75% -12.82% -12.44%
1 Year -36.17% -36.11% -35.88%
Since Inception -11.01% -11.08% -10.52%
Year-to-Date -31.60% -31.68% -31.65%
1 Month -7.67% -7.76% -8.06%
3 Months -1.91% -1.91% -2.19%
Since Inception -25.65% -25.78% -25.06%
Year-to-Date -29.31% -29.38% -29.03%
1 Month 3.36% 3.36% 3.83%
3 Months -8.16% -8.10% -8.03%
Since Inception -23.15% -23.28% -22.19%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 12/01/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
6.05 241 HK ALIBABA HEALTH BRXVS60 0.85 10,973,900 9,324,781.98
5.58 6618 HK JD HEALTH INTERN BMW8R04 8.41 1,022,450 8,595,993.06
5.01 DOCS DOXIMITY INC-CLASS A BMD22Y4 34.78 222,052 7,722,968.56
4.35 DXCM DEXCOM INC B0796X4 118.03 56,768 6,700,327.04
4.29 A AGILENT TECHNOLOGIES INC 2520153 156.12 42,317 6,606,530.04
4.10 TDOC TELADOC HEALTH INC BYQRFY1 29.00 217,910 6,319,390.00
4.10 MASI MASIMO CORP B1YWR63 145.74 43,282 6,307,918.68
3.97 LH LABORATORY CP 2586122 241.77 25,302 6,117,264.54
3.85 AMN AMN HEALTHCARE 2813552 122.15 48,532 5,928,183.80
3.76 ONEM 1LIFE HEALTHCARE INC BKMG1N5 16.98 341,318 5,795,579.64
3.76 RMD AU RESMED INC-CDI 6221667 22.85 253,371 5,789,335.47
3.72 UNH UNITEDHEALTH GROUP INC 2917766 535.26 10,702 5,728,352.52
3.52 ILMN ILLUMINA INC 2613990 220.86 24,531 5,417,916.66
3.42 PACB PACIFIC BIOSCIEN B4N8MH9 11.08 475,045 5,263,498.60
3.29 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 108.37 46,822 5,074,100.14
3.12 SGFY SIGNIFY HEALTH-A BMD8TD0 28.64 167,932 4,809,572.48
3.09 MDRX ALLSCRIPTS HEALT 2710039 18.90 252,175 4,766,107.50
3.09 VCYT VERACYTE INC BFTWZY0 28.83 165,239 4,763,840.37
2.89 TNDM TANDEM DIABETES CARE INC BF3W461 42.62 104,318 4,446,033.16
2.50 OMCL OMNICELL INC 2789523 50.96 75,682 3,856,754.72
2.31 TWST TWIST BIOSCIENCE CORP BGKG6G7 27.86 127,704 3,557,833.44
2.13 PHR PHREESIA INC BKF9DQ8 28.15 116,378 3,276,040.70
1.96 RCM R1 RCM INC BP2S437 9.02 335,379 3,025,118.58
1.89 1833 HK PING AN HEALTHCA BDRYVB3 2.56 1,138,100 2,908,526.55
1.72 NXGN NEXTGEN HEALTHCARE INC BF5L3D6 20.57 129,072 2,655,011.04
1.63 COP GR COMPUGROUP MEDIC BMY7CH1 39.01 64,507 2,516,396.01
1.18 AMWL AMERICAN WELL -A BN0SDK5 3.77 480,322 1,810,813.94
1.05 NVTA INVITAE CORP BVVCNT1 2.97 543,167 1,613,205.99
1.03 HIMS HIMS & HERS HEALTH INC BN46048 6.38 249,584 1,592,345.92
0.93 4480 JP MEDLEY INC BK93ZN7 30.75 46,391 1,426,575.30
0.90 SHCR SHARECARE INC BJL95B4 2.07 666,707 1,380,083.49
0.87 DCGO DOCGO INC BKP4P23 7.22 184,472 1,331,887.84
0.86 BNGO BIONANO GENOMICS INC BFY8K60 1.98 671,009 1,328,597.82
0.72 SENS SENSEONICS HOLDINGS INC BYQNYR5 1.16 955,808 1,108,737.28
0.63 CPSI COMPUTER PROGRAM 2872122 29.28 33,039 967,381.92
0.58 LFST LIFESTANCE HEALT BN0TRB7 5.55 162,227 900,359.85
0.57 DH DEFINITIVE HEALT BMGSDK2 12.00 73,539 882,468.00
0.55 GDRX GOODRX HOLDIN-A BMTVQT8 5.16 163,913 845,791.08
0.51 OPRX OPTIMIZERX CORP BF5MM09 20.36 38,914 792,289.04
0.39 HLTH CUE HEALTH INC BM9J045 2.99 202,468 605,379.32
0.12 CASH 1.00 180,603 180,602.34
Holdings are subject to change.

Sector Breakdown As of 10/31/22

Sector Weight (%)
Health Care 93.7
Consumer Discretionary 4.5
Financials 1.8

Source: AltaVista Research, LLC

Country Breakdown As of 10/31/22

Country Weight (%)
United States 88.1
China 6.3
Hong Kong 3.7
Germany 1.9

Source: AltaVista Research, LLC

ETF Characteristics As of 12/01/22

Return on Equity -37.20%
Weighted Avg. Market Cap 32,399 M
2021 2022
Price-to-earnings -49.11 -9.40
Price-to-book value 2.94 4.32

Source: AltaVista Research, LLC

ETF Risk Stats As of 11/30/22

Versus Beta
S&P 500 0.85
MSCI EAFE 0.81
MSCI Emg. Mkts 0.73
Standard Deviation 22.40%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.

Back to Top